TOI Stock: The Oncology Institute, Inc. Stock Price, Analysis & Insights
Get live toi stock price $3.97, comprehensive The Oncology Institute, Inc. stock analysis, charts, news, and expert forecast. Real-time toi stock data and investment insights.
Loading chart...
Company Overview
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Company Information
- CEO
- Daniel Virnich FACHE,
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 825
Contact Information
- Address
- 18000 Studebaker Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.16) may provide portfolio stability
Business Model & Strategy
The Oncology Institute, Inc. operates in the Medical - Care Facilities industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Daniel Virnich FACHE,, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Care Facilities model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
The Oncology Institute, Inc. competes in the Medical - Care Facilities within the broader Healthcare. With 387.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, The Oncology Institute, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating The Oncology Institute, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for The Oncology Institute, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for The Oncology Institute, Inc.
- ⚠Investors should consider how The Oncology Institute, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
387.35M
P/E Ratio
-5.93
Beta
0.16
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 387.35M market capitalization
- Trading Volume: 8.65M shares traded today
- Price Range: 52-week range of $0.13 - $4.88
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for The Oncology Institute, Inc.
The Oncology Institute, Inc. (TOI) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 387.35M, the company represents a significant player in its market. The stock is currently trading at $3.97 with a positivedaily change of 28.90%.
The company's 825 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -5.93, beta of 0.16, and 52-week price range from $0.13 to $4.88when evaluating investment opportunities.
Why Invest in The Oncology Institute, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Daniel Virnich FACHE,
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.